【港股异动 | 乐普生物-B(02157.HK)午后涨超7% CDH17靶向ADC获批临床 该药年初已达成海外授权】智通

智通财经
Jun 20
【港股异动 | 乐普生物-B(02157.HK)午后涨超7% CDH17靶向ADC获批临床 该药年初已达成海外授权】智通财经APP获悉,乐普生物-B(02157.HK)午后涨超7%,截至发稿,涨5.45%,报5.61港元,成交额9405.12万港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10